HEADER SUGAR BINDING PROTEIN 17-SEP-20 7AEN TITLE GALECTIN-8 N-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN IN COMPLEX WITH TITLE 2 METHYL 3-O-((7-CARBOXY)QUINOLIN-2-YL)-METHOXY)-BETA-D- TITLE 3 GALACTOPYRANOSIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 2 OF GALECTIN-8; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GAL-8,PO66 CARBOHYDRATE-BINDING PROTEIN,PO66-CBP,PROSTATE COMPND 5 CARCINOMA TUMOR ANTIGEN 1,PCTA-1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS8; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.HASSAN,V.S.KLAVERN,M.HAKANSSON,M.ANDERLUH,T.TOMASIC,Z.JAKOPIN, AUTHOR 2 J.U.NILSSON,R.KOVACIC,B.WALSE,C.DIEHL REVDAT 3 31-JAN-24 7AEN 1 REMARK REVDAT 2 09-FEB-22 7AEN 1 COMPND JRNL HETNAM HETSYN REVDAT 1 28-JUL-21 7AEN 0 JRNL AUTH M.HASSAN,F.BAUSSIERE,S.GUZELJ,A.P.SUNDIN,M.HAKANSSON, JRNL AUTH 2 R.KOVACIC,H.LEFFLER,T.TOMASIC,M.ANDERLUH,Z.JAKOPIN, JRNL AUTH 3 U.J.NILSSON JRNL TITL STRUCTURE-GUIDED DESIGN OF D-GALACTAL DERIVATIVES WITH HIGH JRNL TITL 2 AFFINITY AND SELECTIVITY FOR THE GALECTIN-8 N-TERMINAL JRNL TITL 3 DOMAIN JRNL REF ACS MED.CHEM.LETT. V. 12 1745 2021 JRNL REFN ISSN 1948-5875 JRNL DOI 10.1021/ACSMEDCHEMLETT.1C00371 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.VAN KLAVEREN,A.P.SUNDIN,Z.JAKOPIN,M.ANDERLUH,H.LEFFLER, REMARK 1 AUTH 2 U.J.NILSSON,T.TOMASIC REMARK 1 TITL SELECTIVE GALECTIN-8N LIGANDS: THE DESIGN AND SYNTHESIS OF REMARK 1 TITL 2 PHTHALAZINONE-D-GALACTALS REMARK 1 REF CHEMMEDCHEM V. N/A 2021 REMARK 1 REFN ESSN 1860-7187 REMARK 1 DOI 10.1002/CMDC.202100575 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.GIRARDI,M.MANNA,S.VAN KLAVEREN,T.TOMASIC,Z.JAKOPIN, REMARK 1 AUTH 2 H.LEFFLER,U.J.NILSSON,D.RICKLIN,J.MRAVLJAK,O.SCHWARDT, REMARK 1 AUTH 3 M.ANDERLUH REMARK 1 TITL SELECTIVE MONOVALENT GALECTIN-8 LIGANDS BASED ON REMARK 1 TITL 2 3-LACTOYLGALACTOSIDE REMARK 1 REF CHEMMEDCHEM V. N/A 2021 REMARK 1 REFN ESSN 1860-7187 REMARK 1 DOI 10.1002/CMDC.202100514 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1910 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2602 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.57 REMARK 3 BIN R VALUE (WORKING SET) : 0.3220 REMARK 3 BIN FREE R VALUE SET COUNT : 148 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2378 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.25000 REMARK 3 B22 (A**2) : 1.37000 REMARK 3 B33 (A**2) : -0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.112 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.095 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.698 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.983 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.963 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2563 ; 0.013 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2393 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3482 ; 1.808 ; 1.675 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5567 ; 1.359 ; 1.599 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 313 ; 7.598 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;28.487 ;21.912 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 436 ;13.579 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;19.721 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 340 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2823 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 550 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1212 ; 5.257 ; 3.066 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1213 ; 5.255 ; 3.067 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1513 ; 5.735 ; 4.591 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1514 ; 5.734 ; 4.593 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1351 ; 6.517 ; 3.607 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1351 ; 6.517 ; 3.606 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1962 ; 7.847 ; 5.220 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2766 ; 7.821 ;37.356 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2717 ; 7.647 ;36.880 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 4956 ; 4.029 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 14 160 B 14 160 4484 0.13 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7AEN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1292111276. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 293.5 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35999 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 49.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.69000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5GZD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BUFFER (10MM TRIS/HCL PH 8.0, 150 MM REMARK 280 NACL, 10 MM LACTOSE AND 1 MM TCEP) MIXED WITH RESERVOIR 25% (W/V) REMARK 280 PEG 2000 MONOMETHYLETHYER (MME), A CRYO SOLUTION (10 MM TRIS/ REMARK 280 HCL PH 8.0, 50 MM NACL, 10 MM LACTOSE, 25% (W/V) PEG 2000 MME, REMARK 280 20% ETHYLENE GLYCOL (EG) AND 1 MM TCEP) AND FLASH-FROZEN IN REMARK 280 LIQUID NITROGEN. A CO-CRYSTAL WITH LACTOSE, GROWN FROM A SEEDED REMARK 280 DROP WITH 24% (W/V) PEG 2000 MME IN THE RESERVOIR, WAS USED TO REMARK 280 SOAK IN COMPOUND 1 BY TRANSFERRING CRYSTALS IN THREE STEPS TO REMARK 280 DIFFERENT SOAKING DROPS. FIRST TO A 2 UL DROP WITH GLYCEROL ( 20% REMARK 280 (V/V) GLYCEROL, 25% (W/V PEG 2000 MME, 10 MM TRIS/HCL PH 8.0, REMARK 280 50 MM NACL AND 1 MM TCEP) AND SECONDLY TO A 2 UL DROP WITH 10 MM REMARK 280 COMPOUND 1 (10 MM TRIS/HCL PH 8.0, 50 MM NACL, 5 MM COMPOUND 1, REMARK 280 25% (W/V) PEG 2000 MME AND 1 MM TCEP) AND THIRDLY TO A SECOND REMARK 280 DROP WITH 5 MM COMPOUND 1 (SAME COMPOSITION AS BEFORE)., LIQUID REMARK 280 DIFFUSION, TEMPERATURE 293.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.22600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.35600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.56200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.35600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.22600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.56200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 155 REMARK 465 ASP B 156 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 344 O HOH B 402 1.95 REMARK 500 C6 R8B A 201 O HOH A 310 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASP B 42 O HOH B 385 2654 2.00 REMARK 500 O HOH A 361 O HOH B 427 4455 2.08 REMARK 500 O LEU A 8 NZ LYS B 57 3654 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 72 -131.14 58.48 REMARK 500 ARG B 72 -132.08 62.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R8B A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R8B B 201 DBREF 7AEN A 7 156 UNP O00214 LEG8_HUMAN 7 156 DBREF 7AEN B 7 156 UNP O00214 LEG8_HUMAN 7 156 SEQRES 1 A 150 ASN LEU GLN ASN ILE ILE TYR ASN PRO VAL ILE PRO PHE SEQRES 2 A 150 VAL GLY THR ILE PRO ASP GLN LEU ASP PRO GLY THR LEU SEQRES 3 A 150 ILE VAL ILE ARG GLY HIS VAL PRO SER ASP ALA ASP ARG SEQRES 4 A 150 PHE GLN VAL ASP LEU GLN ASN GLY SER SER MET LYS PRO SEQRES 5 A 150 ARG ALA ASP VAL ALA PHE HIS PHE ASN PRO ARG PHE LYS SEQRES 6 A 150 ARG ALA GLY CYS ILE VAL CYS ASN THR LEU ILE ASN GLU SEQRES 7 A 150 LYS TRP GLY ARG GLU GLU ILE THR TYR ASP THR PRO PHE SEQRES 8 A 150 LYS ARG GLU LYS SER PHE GLU ILE VAL ILE MET VAL LEU SEQRES 9 A 150 LYS ASP LYS PHE GLN VAL ALA VAL ASN GLY LYS HIS THR SEQRES 10 A 150 LEU LEU TYR GLY HIS ARG ILE GLY PRO GLU LYS ILE ASP SEQRES 11 A 150 THR LEU GLY ILE TYR GLY LYS VAL ASN ILE HIS SER ILE SEQRES 12 A 150 GLY PHE SER PHE SER SER ASP SEQRES 1 B 150 ASN LEU GLN ASN ILE ILE TYR ASN PRO VAL ILE PRO PHE SEQRES 2 B 150 VAL GLY THR ILE PRO ASP GLN LEU ASP PRO GLY THR LEU SEQRES 3 B 150 ILE VAL ILE ARG GLY HIS VAL PRO SER ASP ALA ASP ARG SEQRES 4 B 150 PHE GLN VAL ASP LEU GLN ASN GLY SER SER MET LYS PRO SEQRES 5 B 150 ARG ALA ASP VAL ALA PHE HIS PHE ASN PRO ARG PHE LYS SEQRES 6 B 150 ARG ALA GLY CYS ILE VAL CYS ASN THR LEU ILE ASN GLU SEQRES 7 B 150 LYS TRP GLY ARG GLU GLU ILE THR TYR ASP THR PRO PHE SEQRES 8 B 150 LYS ARG GLU LYS SER PHE GLU ILE VAL ILE MET VAL LEU SEQRES 9 B 150 LYS ASP LYS PHE GLN VAL ALA VAL ASN GLY LYS HIS THR SEQRES 10 B 150 LEU LEU TYR GLY HIS ARG ILE GLY PRO GLU LYS ILE ASP SEQRES 11 B 150 THR LEU GLY ILE TYR GLY LYS VAL ASN ILE HIS SER ILE SEQRES 12 B 150 GLY PHE SER PHE SER SER ASP HET R8B A 201 27 HET GOL A 202 6 HET CL A 203 1 HET R8B B 201 27 HETNAM R8B METHYL 3-O-((7-CARBOXY) QUINOLIN-2-YL)-METHYL)-BETA-D- HETNAM 2 R8B GALACTOPYRANOSIDE HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN R8B 2-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(HYDROXYMETHYL)- HETSYN 2 R8B 6-METHOXY-3,5-BIS(OXIDANYL)OXAN-4- HETSYN 3 R8B YL]OXYMETHYL]QUINOLINE-7-CARBOXYLIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 R8B 2(C18 H21 N O8) FORMUL 4 GOL C3 H8 O3 FORMUL 5 CL CL 1- FORMUL 7 HOH *247(H2 O) HELIX 1 AA1 GLY A 131 ILE A 135 5 5 HELIX 2 AA2 GLY B 131 ILE B 135 5 5 SHEET 1 AA1 6 GLN A 9 TYR A 13 0 SHEET 2 AA1 6 ASN A 145 SER A 152 -1 O PHE A 151 N GLN A 9 SHEET 3 AA1 6 LEU A 32 HIS A 38 -1 N HIS A 38 O ASN A 145 SHEET 4 AA1 6 SER A 102 VAL A 109 -1 O ILE A 105 N ILE A 35 SHEET 5 AA1 6 LYS A 113 VAL A 118 -1 O GLN A 115 N MET A 108 SHEET 6 AA1 6 LYS A 121 GLY A 127 -1 O LEU A 124 N VAL A 116 SHEET 1 AA2 6 PHE A 19 THR A 22 0 SHEET 2 AA2 6 THR A 137 GLY A 142 -1 O LEU A 138 N GLY A 21 SHEET 3 AA2 6 PHE A 46 ASN A 52 -1 N ASP A 49 O GLY A 139 SHEET 4 AA2 6 ASP A 61 ARG A 69 -1 O PHE A 64 N LEU A 50 SHEET 5 AA2 6 CYS A 75 ILE A 82 -1 O CYS A 75 N ARG A 69 SHEET 6 AA2 6 LYS A 85 TRP A 86 -1 O LYS A 85 N ILE A 82 SHEET 1 AA3 6 PHE A 19 THR A 22 0 SHEET 2 AA3 6 THR A 137 GLY A 142 -1 O LEU A 138 N GLY A 21 SHEET 3 AA3 6 PHE A 46 ASN A 52 -1 N ASP A 49 O GLY A 139 SHEET 4 AA3 6 ASP A 61 ARG A 69 -1 O PHE A 64 N LEU A 50 SHEET 5 AA3 6 CYS A 75 ILE A 82 -1 O CYS A 75 N ARG A 69 SHEET 6 AA3 6 GLU A 90 THR A 92 -1 O GLU A 90 N CYS A 78 SHEET 1 AA4 6 GLN B 9 TYR B 13 0 SHEET 2 AA4 6 ASN B 145 SER B 152 -1 O PHE B 151 N GLN B 9 SHEET 3 AA4 6 LEU B 32 HIS B 38 -1 N VAL B 34 O GLY B 150 SHEET 4 AA4 6 SER B 102 VAL B 109 -1 O ILE B 105 N ILE B 35 SHEET 5 AA4 6 LYS B 113 VAL B 118 -1 O GLN B 115 N MET B 108 SHEET 6 AA4 6 LYS B 121 GLY B 127 -1 O LEU B 124 N VAL B 116 SHEET 1 AA5 6 PHE B 19 THR B 22 0 SHEET 2 AA5 6 THR B 137 GLY B 142 -1 O LEU B 138 N GLY B 21 SHEET 3 AA5 6 PHE B 46 ASN B 52 -1 N ASP B 49 O GLY B 139 SHEET 4 AA5 6 ASP B 61 ARG B 69 -1 O PHE B 64 N LEU B 50 SHEET 5 AA5 6 CYS B 75 ILE B 82 -1 O CYS B 75 N ARG B 69 SHEET 6 AA5 6 LYS B 85 TRP B 86 -1 O LYS B 85 N ILE B 82 SHEET 1 AA6 6 PHE B 19 THR B 22 0 SHEET 2 AA6 6 THR B 137 GLY B 142 -1 O LEU B 138 N GLY B 21 SHEET 3 AA6 6 PHE B 46 ASN B 52 -1 N ASP B 49 O GLY B 139 SHEET 4 AA6 6 ASP B 61 ARG B 69 -1 O PHE B 64 N LEU B 50 SHEET 5 AA6 6 CYS B 75 ILE B 82 -1 O CYS B 75 N ARG B 69 SHEET 6 AA6 6 GLU B 90 THR B 92 -1 O GLU B 90 N CYS B 78 CISPEP 1 ILE A 17 PRO A 18 0 7.38 CISPEP 2 LYS A 57 PRO A 58 0 -5.99 CISPEP 3 ILE B 17 PRO B 18 0 4.63 CISPEP 4 LYS B 57 PRO B 58 0 -2.05 SITE 1 AC1 14 ARG A 45 GLN A 47 ARG A 59 HIS A 65 SITE 2 AC1 14 ASN A 67 ARG A 69 ASN A 79 GLU A 89 SITE 3 AC1 14 TYR A 141 GLY A 142 HOH A 310 HOH A 340 SITE 4 AC1 14 HOH A 363 HOH A 383 SITE 1 AC2 2 TYR A 13 TYR B 13 SITE 1 AC3 4 ASP A 112 LYS A 113 GLY B 131 LYS B 134 SITE 1 AC4 14 ARG B 45 GLN B 47 ARG B 59 HIS B 65 SITE 2 AC4 14 ASN B 67 ARG B 69 ASN B 79 TRP B 86 SITE 3 AC4 14 GLU B 89 TYR B 141 GLY B 142 HOH B 309 SITE 4 AC4 14 HOH B 337 HOH B 347 CRYST1 54.452 61.124 84.712 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018365 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016360 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011805 0.00000